Trademark: 88122890
Word
GPCR THERAPEUTICS
Status Date
Monday, May 30, 2022
Filing Date
Wednesday, September 19, 2018
Published for Opposition
Tuesday, February 26, 2019
Abandoned Date
Monday, May 30, 2022
5 Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer
44 Clinical and medical testing for medical diagnostic purposes; Medical testing for diagnostic purposes of reagents, clinical and non-clinical samples, nucleic acids, proteins, and pharmacological formulations
10 Medical diagnostic apparatus for detecting cancer
42 Biological, medical, and scientific research in the field of cancer research, diagnosis, and treatment; Scientific research and development in the biological, medical, health care, or pharmacological fields; Clinical and pharmacological research and testing services performed in conjunction with clinical trials; Scientific research and development services in the fields of biotechnology, new drug development, pharmacological formulation, and microbiological research; Scientific research consultation and information services in the biological, medical, health care, or pharmacological fields; Information technology management consultation and new product development services in the biological, medical, health care, or pharmacological fields
The mark consists of the uppercase letters "GP" on top of the uppercase letters "CR" next to the word "therapeutics" in lowercase letters, all of which appear on top of a repeating pattern of generally horizontal lines that each begin on the left with a concave curved portion, followed by a combination of angled, straight, and zig zag portions, and ending with another straight portion. The lines are oriented on top of each other and do not intersect, and portions of the top and bottom lines are cut off to give the mark a generally rectangular appearance.
Color is not claimed as a feature of the mark.
"GPCR" AND "THERAPEUTICS"
May 31, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 30, 2022
Abandonment - No Use Statement Filed
Oct 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2021
Sou Extension 5 Granted
Oct 22, 2021
Sou Extension 5 Filed
Oct 22, 2021
Teas Extension Received
Apr 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 23, 2021
Sou Extension 4 Granted
Apr 23, 2021
Sou Extension 4 Filed
Apr 23, 2021
Teas Extension Received
Oct 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 7, 2020
Sou Extension 3 Granted
Oct 7, 2020
Sou Extension 3 Filed
Oct 7, 2020
Teas Extension Received
Apr 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 1, 2020
Sou Extension 2 Granted
Apr 1, 2020
Sou Extension 2 Filed
Apr 1, 2020
Teas Extension Received
Oct 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2019
Sou Extension 1 Granted
Oct 4, 2019
Sou Extension 1 Filed
Oct 4, 2019
Teas Extension Received
May 8, 2019
Corrected Noa E-Mailed
May 7, 2019
Notice Of Allowance Correction Entered
May 7, 2019
Case Assigned To Intent To Use Paralegal
Apr 24, 2019
Teas Post Publication Amendment Received
Apr 23, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 26, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 26, 2019
Published For Opposition
Feb 6, 2019
Notification Of Notice Of Publication E-Mailed
Jan 17, 2019
Approved For Pub - Principal Register
Jan 17, 2019
Teas/Email Correspondence Entered
Jan 17, 2019
Correspondence Received In Law Office
Jan 16, 2019
Assigned To Lie
Jan 10, 2019
Teas Change Of Correspondence Received
Jan 10, 2019
Teas Response To Office Action Received
Jan 3, 2019
Notification Of Non-Final Action E-Mailed
Jan 3, 2019
Non-Final Action E-Mailed
Jan 3, 2019
Non-Final Action Written
Jan 1, 2019
Assigned To Examiner
Sep 26, 2018
Notice Of Design Search Code E-Mailed
Sep 25, 2018
New Application Office Supplied Data Entered In Tram
Sep 22, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
